Multi-layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/beta-catenin signaling activation (Review).
Katoh M.
Int J Mol Med. 2018 Aug;42(2):713-725. doi: 10.3892/ijmm.2018.3689. Epub 2018 May 17.
CXCR4 regulates macrophage M1 polarization by altering glycolysis to promote prostate fibrosis.
Zhang Y, Zhang C, Feng R, Meng T, Peng W, Song J, Ma W, Xu W, Chen X, Chen J, Liang C.
Cell Commun Signal. 2024 Sep 26;22(1):456. doi: 10.1186/s12964-024-01828-y.
Resveratrol improves prostate fibrosis during progression of urinary dysfunction in chronic prostatitis.
He Y, Zeng HZ, Yu Y, Zhang JS, Duan X, Zeng XN, Gong FT, Liu Q, Yang B.
Environ Toxicol Pharmacol. 2017 Sep;54:120-124. doi: 10.1016/j.etap.2017.06.025. Epub 2017 Jul 1.
Azithromycin: mechanisms of action and their relevance for clinical applications.
Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, Perletti G, Verleden GM, Vos R.
Pharmacol Ther. 2014 Aug;143(2):225-45. doi: 10.1016/j.pharmthera.2014.03.003. Epub 2014 Mar 11.
Resveratrol reduces inflammation-related Prostate Fibrosis.
Vicari E, Arancio A, Catania VE, Vicari BO, Sidoti G, Castiglione R, Malaguarnera M.
Int J Med Sci. 2020 Jul 19;17(13):1864-1870. doi: 10.7150/ijms.44443. eCollection 2020.
Health benefits of astaxanthin against age-related diseases of multiple organs: A comprehensive review.
Alugoju P, Krishna Swamy VKD, Anthikapalli NVA, Tencomnao T.
Crit Rev Food Sci Nutr. 2023;63(31):10709-10774. doi: 10.1080/10408398.2022.2084600. Epub 2022 Jun 16.
Resveratrol improves prostate fibrosis during progression of urinary dysfunction in chronic prostatitis by mast cell suppression.
Zeng H, He Y, Yu Y, Zhang J, Zeng X, Gong F, Liu Q, Yang B.
Mol Med Rep. 2018 Jan;17(1):918-924. doi: 10.3892/mmr.2017.7960. Epub 2017 Nov 3.
Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study.
Kitko CL, Arora M, DeFilipp Z, Zaid MA, Di Stasi A, Radojcic V, Betts CB, Coussens LM, Meyers ML, Qamoos H, Ordentlich P, Kumar V, Quaranto C, Schmitt A, Gu Y, Blazar BR, Wang TP, Salhotra A, Pusic I, Jagasia M, Lee SJ.
J Clin Oncol. 2023 Apr 1;41(10):1864-1875. doi: 10.1200/JCO.22.00958. Epub 2022 Dec 2.
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Diseases and Injuries Collaborators.
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
YAP1 Recognizes Inflammatory and Mechanical Cues to Exacerbate Benign Prostatic Hyperplasia via Promoting Cell Survival and Fibrosis.
Lin D, Luo C, Wei P, Zhang A, Zhang M, Wu X, Deng B, Li Z, Cui K, Chen Z.
Adv Sci (Weinh). 2024 Feb;11(5):e2304274. doi: 10.1002/advs.202304274. Epub 2023 Dec 4.
